Journal Home
Search for

Volume 49, Issue 1, Pages 37-42 (January 2010)


View previous. 13 of 32 View next.

Moje First Metatarsophalangeal Replacement—A Case Series with Functional Outcomes Using the AOFAS-HMI Score

Mark Brewster, MRCS1Corresponding Author Informationemail address, John McArthur, MRCS2, Cyril Mauffrey, MRCS3, Andrew Charles Lewis, MRCS3, Peter Hull, MRCS2, James Ramos, LMS, MD, PhD, FRCS (Trauma & Orth)4

Abstract 

We report the functional results of a case series of Moje first metatarsophalangeal total joint replacements carried out between February 2001 and November 2006. All patients who underwent Moje arthroplasty under the care of a single surgeon were included; outcome scores and complications were recorded annually. A total of 32 joints in 29 consecutive patients were followed for a mean duration of 34 (range 6 to 74) months, and the mean patient age at the time of operation was 56 (range 38 to 79) years. Hallux rigidus was the primary diagnosis in 28 (87.5%) of the cases. The mean American Orthopaedic Foot & Ankle Society Hallux-Metatarsophalangeal-Interphalangeal score at final follow-up was 74/100 (range 9 to 100), with 13 (40.63%) joints rated good to excellent. Two (6.25%) joints were revised to arthrodesis at a mean of 52 (range 41 to 63) months following the arthroplasty procedure, and the overall prevalence of postoperative complications was 6 (18.75%). Based on these results, we concluded that first MTPJ total joint replacement with the Moje device remains promising, but still has room for improvement before the results match those obtained with larger joint (knee, hip) arthroplasty.

Level of Clinical Evidence4

1 Orthopaedic Specialist Registrar, Heart of England NHS Trust, West Midlands, UK

2 Orthopaedic Registrar, University Hospitals Coventry and Warwickshire, Coventry, UK

3 Orthopaedic Specialist Registrar, Heart of England NHS Trust, Solihull, UK

4 Consultant Foot and Ankle Surgeon, Foot & Ankle Specialist Service, Heart of England NHS Trust, West Midlands, UK

Corresponding Author InformationAddress correspondence to: Mark Brewster MRCS, Orthopaedic Specialist Registrar, Heart of England NHS Trust, 8 Four Oaks Common Road, Sutton Coldfield, West Midlands, B744NJ, UK.

 Financial Disclosure: None reported.

 Conflict of Interest: None reported.

PII: S1067-2516(09)00353-6

doi:10.1053/j.jfas.2009.08.009


View previous. 13 of 32 View next.